PL404138A1 - Pochodne kwasu benzoesowego jako inhibitory receptora IL-15Rα - Google Patents

Pochodne kwasu benzoesowego jako inhibitory receptora IL-15Rα

Info

Publication number
PL404138A1
PL404138A1 PL404138A PL40413813A PL404138A1 PL 404138 A1 PL404138 A1 PL 404138A1 PL 404138 A PL404138 A PL 404138A PL 40413813 A PL40413813 A PL 40413813A PL 404138 A1 PL404138 A1 PL 404138A1
Authority
PL
Poland
Prior art keywords
benzoic acid
acid derivatives
receptor inhibitors
overproduction
tautomers
Prior art date
Application number
PL404138A
Other languages
English (en)
Inventor
Katarzyna Koziak
Barbara Żyżyńska-Granica
Sławomir Filipek
Szymon Niewieczerzał
Bartosz Trzaskowski
Oliwia Zegrocka-Stendel
Małgorzata Dutkiewicz
Piotr Krzeczyński
Elżbieta Kaczmarek
Magdalena Winiarska
Original Assignee
Warszawski Uniwersytet Medyczny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warszawski Uniwersytet Medyczny filed Critical Warszawski Uniwersytet Medyczny
Priority to PL404138A priority Critical patent/PL404138A1/pl
Priority to PCT/IB2014/000894 priority patent/WO2014191822A1/en
Publication of PL404138A1 publication Critical patent/PL404138A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Wynalazek dotyczy zastosowania pchodnych kwasu benzoesowego o wzorze (I), ich tautomerów, izomerów, farmaceutycznie dopuszczalnych soli i solwatów, do zapobiegania i leczenia chorób, u podłoża których leży nadprodukcja interleukiny 15.
PL404138A 2013-05-31 2013-05-31 Pochodne kwasu benzoesowego jako inhibitory receptora IL-15Rα PL404138A1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL404138A PL404138A1 (pl) 2013-05-31 2013-05-31 Pochodne kwasu benzoesowego jako inhibitory receptora IL-15Rα
PCT/IB2014/000894 WO2014191822A1 (en) 2013-05-31 2014-05-29 BENZOIC ACID DERIVATIVES AS IL-15Rα RECEPTOR INHIBITORS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL404138A PL404138A1 (pl) 2013-05-31 2013-05-31 Pochodne kwasu benzoesowego jako inhibitory receptora IL-15Rα

Publications (1)

Publication Number Publication Date
PL404138A1 true PL404138A1 (pl) 2014-12-08

Family

ID=51257533

Family Applications (1)

Application Number Title Priority Date Filing Date
PL404138A PL404138A1 (pl) 2013-05-31 2013-05-31 Pochodne kwasu benzoesowego jako inhibitory receptora IL-15Rα

Country Status (2)

Country Link
PL (1) PL404138A1 (pl)
WO (1) WO2014191822A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3366683A1 (en) 2017-02-28 2018-08-29 Acousia Therapeutics GmbH Cyclic amides, acteamides and ureas useful as potassium channel openers
CA3061328A1 (en) 2017-04-24 2018-11-01 University Of Massachusetts Diagnosis and treatment of vitiligo

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4436127A1 (de) * 1994-09-27 1996-03-28 Deutsches Rheumaforschungszent Verwendung von aromatischen Amiden und Säuren zur Behandlung von rheumatischen Erkrankungen
US6924308B1 (en) * 1997-07-30 2005-08-02 Howard L. Elford Therapeutic process for inhibiting NF-κB
US20120178697A9 (en) * 2003-09-22 2012-07-12 Jie Zheng Compositions and methods for the inhibition of dishevelled proteins
CU23472A1 (es) 2004-09-17 2009-12-17 Ct Ingenieria Genetica Biotech Péptido antagonista de la interleucina-15
DE102005005399A1 (de) * 2005-02-05 2006-08-10 Lts Lohmann Therapie-Systeme Ag Isolierung von Atrarsäure, Synthese von Atrarsäure-Derivaten sowie deren Verwendung der Atrarsäure und ihrer Derivate zur Behandlung der benignen Prostatahyperplasie und des Prostatakarzinoms
CN100427082C (zh) * 2005-08-02 2008-10-22 盛华（广州）医药科技有限公司 羟基苯甲酸酯及其类似物在制备预防和治疗病毒性感染药物中的应用
WO2008020042A1 (en) * 2006-08-16 2008-02-21 Action Medicines, S.L. Use of 2, 5-dihydroxybenzene derivatives for the treatment of tissue reactive diseases
US7867989B2 (en) * 2007-06-22 2011-01-11 Vinitha Moolchand Thadani α-glucosidase inhibitors from lichens
WO2010034003A2 (en) * 2008-09-22 2010-03-25 Calcimedica, Inc. Benzylthiotetrazole inhibitors of store operated calcium release
CU23716A1 (es) 2008-09-30 2011-10-05 Ct Ingenieria Genetica Biotech Péptido antagonista de la actividad de la interleucina-15
US8785499B2 (en) * 2009-07-10 2014-07-22 University Of Maryland, Baltimore Targeting NAD biosynthesis in bacterial pathogens

Also Published As

Publication number Publication date
WO2014191822A1 (en) 2014-12-04

Similar Documents

Publication Publication Date Title
PH12016502382A1 (en) Substituted indazole compounds as irak4 inhibitors
PH12018502125A1 (en) Bipyrazole derivatives as jak inhibitors
PH12018500041A1 (en) Substituted aza compoounds as irak-4 inhibitors
PH12018500040A1 (en) Indazole and azaindazole compounds as irak-4 inhibitors
JOP20190174B1 (ar) مثبطات jak1 انتقائية
MD20160106A2 (ro) Compuşi aril sau heteroaril biciclici condensaţi şi utilizarea acestora ca inhibitori IRAK4
EA201590224A1 (ru) Имидазотриазинкарбонитрилы, используемые в качестве ингибиторов киназы
MX2017003695A (es) Pirimidinonas como inhibidores del factor xia.
MX382991B (es) Inhibidores de la arginina metiltransferasa y usos de los mismos.
MY199894A (en) Prmt5 inhibitors and uses thereof
EA201591360A1 (ru) Азабензимидазолы в качестве ингибиторов изозимов фдэ4 для лечения цнс и других расстройств
EA201692249A1 (ru) Ингибиторы фосфатидилинозитол-3-киназы
UA113160C2 (xx) Інгібування il17 і ifn-гамма для лікування аутоімунного запалення
UA110048C2 (uk) Інгібування il17 і ifn-гамма для лікування аутоімунного запалення
EA201791289A1 (ru) Ингибиторы клеточного некроза и связанные с ними способы
EA201790253A1 (ru) Ингибиторы альдостеронсинтазы
EA201790830A1 (ru) Ингибиторы альдостеронсинтазы
MX2018005004A (es) Compuestos de indazol substituidos como inhibidores de rorgammat y sus usos.
EA201791480A1 (ru) Новые производные бензимидазола в качестве антигистаминных агентов
MX2017013099A (es) Metodos para el tratamiento de trastornos inflamatorios.
EA201990313A1 (ru) Производное триазолопиразинона, пригодное в качестве ингибитора фдэ1 человека
EA201500736A1 (ru) Пиразолилкарбоксамиды i в качестве ингибиторов crac каналов
EA201500737A1 (ru) Пиразолилкарбоксамиды ii в качестве ингибиторов crac каналов
PL404138A1 (pl) Pochodne kwasu benzoesowego jako inhibitory receptora IL-15Rα
SA521421098B1 (ar) -h4 مركبات بيريدو بيريميدينات كمثبطات مستقبل هستامين